Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Clinical trial NCT02226120 · COMPLETED
Trial details
- NCT number
- NCT02226120
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-16
- Primary completion
- 2017-12-28
- Enrollment
- 1980
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.